Agenda
Applications for consideration at this meeting
- 1555.1 Endoscopic sleeve gastroplasty for the treatment of patients with Class I and II obesity who have failed first line (lifestyle modification) and second line (pharmacotherapy) treatments
- 1657 Rhenium-188 brachytherapy for non-melanoma skin cancer
- 1665 Radiofrequency echographic multi spectrometry for bone density measurement and determination of osteopenia/osteoporosis
- 1675 Whole Genome Sequencing for the diagnosis of mitochondrial disease
- 1680 Genetic testing for childhood hearing impairment
- 1684 Genetic testing for variants associated with haematological malignancies
- 1685 Ventral rectopexy for the treatment of rectal prolapse and intussusception
- 1686 177 Lutetium PSMA i&t for metastatic castrate resistant prostate cancer
- 1689 Quantification of NT-proBNP in patients with systemic sclerosis, and in patients with diagnosed pulmonary arterial hypertension
- 1690 Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell to treat refractory or relapsed multiple myeloma
- 1691 PromarkerD testing in patients with type 2 diabetes to determine the risk of developing diabetic kidney disease
Related information
Committee: